These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38086310)

  • 21. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer.
    Larue RTHM; Klaassen R; Jochems A; Leijenaar RTH; Hulshof MCCM; van Berge Henegouwen MI; Schreurs WMJ; Sosef MN; van Elmpt W; van Laarhoven HWM; Lambin P
    Acta Oncol; 2018 Nov; 57(11):1475-1481. PubMed ID: 30067421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a radiomics signature on differentially expressed features of
    Cao Q; Li Y; Li Z; An D; Li B; Lin Q
    Radiother Oncol; 2020 May; 146():9-15. PubMed ID: 32065875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of CT Radiomics and Delta Radiomics for Survival Evaluation in Locally Advanced Nasopharyngeal Carcinoma with Concurrent Chemoradiotherapy.
    Huang YC; Huang SM; Yeh JH; Chang TC; Tsan DL; Lin CY; Tu SJ
    Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
    Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
    Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
    Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
    Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
    Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-specific deep learning model to enhance 4D-CBCT image for radiomics analysis.
    Zhang Z; Huang M; Jiang Z; Chang Y; Lu K; Yin FF; Tran P; Wu D; Beltran C; Ren L
    Phys Med Biol; 2022 Apr; 67(8):. PubMed ID: 35313293
    [No Abstract]   [Full Text] [Related]  

  • 28. Development and validation of an [
    Takahashi N; Tanaka S; Umezawa R; Takanami K; Takeda K; Yamamoto T; Suzuki Y; Katsuta Y; Kadoya N; Jingu K
    Acta Oncol; 2023 Feb; 62(2):159-165. PubMed ID: 36794365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeatability of CBCT radiomic features and their correlation with CT radiomic features for prostate cancer.
    Delgadillo R; Spieler BO; Ford JC; Kwon D; Yang F; Studenski M; Padgett KR; Abramowitz MC; Dal Pra A; Stoyanova R; Pollack A; Dogan N
    Med Phys; 2021 May; 48(5):2386-2399. PubMed ID: 33598943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced CT-based radiomic analysis for determining the response to anti-programmed death-1 therapy in esophageal squamous cell carcinoma patients: A pilot study.
    Yang Q; Huang H; Zhang G; Weng N; Ou Z; Sun M; Luo H; Zhou X; Gao Y; Wu X
    Thorac Cancer; 2023 Nov; 14(33):3266-3274. PubMed ID: 37743537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-region radiomics signature: Integrating primary tumor and lymph node computed tomography features improves survival prediction in esophageal squamous cell cancer.
    Lu N; Zhang WJ; Dong L; Chen JY; Zhu YL; Zhang SH; Fu JH; Yin SH; Li ZC; Xie CM
    Comput Methods Programs Biomed; 2021 Sep; 208():106287. PubMed ID: 34311416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
    Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics.
    Jin X; Zheng X; Chen D; Jin J; Zhu G; Deng X; Han C; Gong C; Zhou Y; Liu C; Xie C
    Eur Radiol; 2019 Nov; 29(11):6080-6088. PubMed ID: 31028447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy.
    Cui J; Li L; Liu N; Hou W; Dong Y; Yang F; Zhu S; Li J; Yuan S
    Biomark Res; 2023 Apr; 11(1):44. PubMed ID: 37095586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
    Zheng J; Zhang H; Li S; Kang Z; Zheng F; Yao Q; Zhang X; Wu Z; Wang J; Fang W; Li J; Chen G; Chen Y; Chen M
    BMC Cancer; 2023 Dec; 23(1):1193. PubMed ID: 38053017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model.
    Kawahara D; Murakami Y; Awane S; Emoto Y; Iwashita K; Kubota H; Sasaki R; Nagata Y
    Eur Radiol; 2024 Feb; 34(2):1200-1209. PubMed ID: 37589902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using high-repeatable radiomic features improves the cross-institutional generalization of prognostic model in esophageal squamous cell cancer receiving definitive chemoradiotherapy.
    Gong J; Wang Q; Li J; Yang Z; Zhang J; Teng X; Sun H; Cai J; Zhao L
    Insights Imaging; 2024 Oct; 15(1):239. PubMed ID: 39373828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiomics on spatial-temporal manifolds via Fokker-Planck dynamics.
    Stevens JB; Riley BA; Je J; Gao Y; Wang C; Mowery YM; Brizel DM; Yin FF; Liu JG; Lafata KJ
    Med Phys; 2024 May; 51(5):3334-3347. PubMed ID: 38190505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of SBRT response in liver cancer by combining original and delta cone-beam CT radiomics: a pilot study.
    Yang P; Shan J; Ge X; Zhou Q; Ding M; Niu T; Du J
    Phys Eng Sci Med; 2024 Mar; 47(1):295-307. PubMed ID: 38165634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment.
    Chen NB; Xiong M; Zhou R; Zhou Y; Qiu B; Luo YF; Zhou S; Chu C; Li QW; Wang B; Jiang HH; Guo JY; Peng KQ; Xie CM; Liu H
    Radiat Oncol; 2022 Nov; 17(1):184. PubMed ID: 36384755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.